These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26159635)

  • 21. Optimal digoxin concentrations for patients with heart failure.
    de Denus S; Spinler SA
    JAMA; 2003 May; 289(20):2643; author reply 2643-4. PubMed ID: 12771103
    [No Abstract]   [Full Text] [Related]  

  • 22. Digoxin in clinical practice: sorting out the facts.
    Doi SA; Landless PN
    Br J Clin Pract; 1995; 49(5):257-61. PubMed ID: 7492463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digoxin: quo vadis?
    Cleland JG; Cullington D
    Circ Heart Fail; 2009 Mar; 2(2):81-5. PubMed ID: 19808321
    [No Abstract]   [Full Text] [Related]  

  • 24. Digoxin in the management of cardiovascular disorders.
    Gheorghiade M; Adams KF; Colucci WS
    Circulation; 2004 Jun; 109(24):2959-64. PubMed ID: 15210613
    [No Abstract]   [Full Text] [Related]  

  • 25. End of the oldest controversy in medicine. Are we ready to conclude the debate on digitalis?
    Packer M
    N Engl J Med; 1997 Feb; 336(8):575-6. PubMed ID: 9023096
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of digoxin on mortality and morbidity in patients with heart failure.
    Digitalis Investigation Group
    N Engl J Med; 1997 Feb; 336(8):525-33. PubMed ID: 9036306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Digitoxin, digoxin. Principles and rules of use, dosage].
    Lechat P
    Rev Prat; 1994 Jun; 44(12):1695-9. PubMed ID: 7939249
    [No Abstract]   [Full Text] [Related]  

  • 28. Digoxin and mortality in chronic heart failure. UK Heart Investigation.
    Lindsay SJ; Kearney MT; Prescott RJ; Fox KA; Nolan J
    Lancet; 1999 Sep; 354(9183):1003. PubMed ID: 10501370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure.
    Bourge RC; Fleg JL; Fonarow GC; Cleland JG; McMurray JJ; van Veldhuisen DJ; Gheorghiade M; Patel K; Aban IB; Allman RM; White-Williams C; White M; Filippatos GS; Anker SD; Ahmed A
    Am J Med; 2013 Aug; 126(8):701-8. PubMed ID: 23490060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of digoxin in comparison with propranolol for treatment of infant supraventricular tachycardia: analysis of a large, national database.
    Moffett BS; Lupo PJ; delaUz CM; Valdes SO; Miyake CY; Decker JA; Kim JJ
    Cardiol Young; 2015 Aug; 25(6):1080-5. PubMed ID: 25216155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical dose of digoxin for treating supraventricular tachycardias after heart surgery.
    Krohn BG; Saenz JM; Eto KK
    Chest; 1989 Apr; 95(4):729-34. PubMed ID: 2924601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex-based differences in the effect of digoxin for the treatment of heart failure.
    Rathore SS; Wang Y; Krumholz HM
    N Engl J Med; 2002 Oct; 347(18):1403-11. PubMed ID: 12409542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on digoxin therapy in congestive heart failure.
    Haji SA; Movahed A
    Am Fam Physician; 2000 Jul; 62(2):409-16. PubMed ID: 10929703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P-glycoprotein makes no contribution to the lower transplacental transfer of digoxin under fetal heart failure, but who should be blamed for?
    Li Y; Hua Y; Zhou K
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():256-7. PubMed ID: 24798074
    [No Abstract]   [Full Text] [Related]  

  • 35. Omeprazole does not modulate pharmacokinetic of digoxin in patients with heart failure.
    Souza FC; Baptista TM; Marques EB; Barros RB; Scaramello CB
    Int J Cardiol; 2015 Jan; 179():343-4. PubMed ID: 25464482
    [No Abstract]   [Full Text] [Related]  

  • 36. Whither digitalis?
    Campbell RW
    Lancet; 1997 Jun; 349(9069):1854-5. PubMed ID: 9217753
    [No Abstract]   [Full Text] [Related]  

  • 37. Inappropriate use of digoxin in the elderly: how widespread is the problem and how can it be solved?
    Haas GJ; Young JB
    Drug Saf; 1999 Mar; 20(3):223-30. PubMed ID: 10221852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of digoxin in the treatment of chronic heart failure.
    Wong B; Flattery MP
    Prog Cardiovasc Nurs; 2006; 21(3):158-61. PubMed ID: 16957464
    [No Abstract]   [Full Text] [Related]  

  • 39. Two cases of clarithromycin-induced digoxin toxicity.
    Guerriero SE; Ehrenpreis E; Gallagher KL
    Pharmacotherapy; 1997; 17(5):1035-7. PubMed ID: 9324195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A perspective on re-evaluating digoxin's role in the current management of patients with chronic systolic heart failure: targeting serum concentration to reduce hospitalization and improve safety profile.
    Adams KF; Ghali JK; Herbert Patterson J; Stough WG; Butler J; Bauman JL; Ventura HO; Sabbah H; Mackowiak JI; van Veldhuisen DJ
    Eur J Heart Fail; 2014 May; 16(5):483-93. PubMed ID: 24574198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.